JPRN-UMIN000031015
Recruiting
未知
Safety and efficacy for day 1 administration of gemcitabine and cisplatin - Safety and efficacy for day 1 administration of gemcitabine and cisplatin
Conditionsrothelial carcinoma
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- rothelial carcinoma
- Sponsor
- Tokyo Metropolitan Tama Medical Center
- Enrollment
- 20
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
A phase I/II study for the safety and efficacy of Panitumumab in combination with TAS-102 for patients with RAS wild-type metastatic colorectal cancer refractory to standard chemotherapyunresectable advanced colorectal cancerJPRN-UMIN000019876Takeda Pharmaceutical Company Limited52
Completed
Not Applicable
Clinical evaluation of the efficacy and safety of Hochuekkito for fatigue in patients with myeloproliferative neoplasmsmyeloproliferative neoplasmsJPRN-UMIN000031519Department of Hematology, Juntendo University School of Medicine110
Recruiting
Early Phase 1
Clinical evaluation of the efficacy and safety of Huayu Tongbi Fomular on rheumatoid arthritisRheumatoid ArthritisITMCTR2024000092Guangdong Provincial Hospital of Chinese Medicine
Completed
Phase 3
Clinical evaluation of the safety and effectiveness of Excilor 2-in-1 Wart Treatment in the treatment of warts on the hands and feetISRCTN39469406Medical Brands66
Unknown
Phase 2
Clinical evaluation of the efficacy and safety of the guideline of oral ingestion of NaCl for children with ileostomyileostomyJPRN-UMIN000016711Division of Pediatric Surgery, Department of Surgery, Kobe University Graduate School of Medicine30